Daily Intelligence Brief
Daily Docket: OpenAI Removes FSU ChatGPT Suit as Bard Adds 9
We tracked 84 new filings. U.S. District Judge Edmund A. Sargus, Jr. still has the Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation (2846) on an Intensive Settlement Process that CMO 55 (Nov. 21, 2024) sets to start on or about Jan. 4, 2027. Lanier Law Firm filed all 9 complaints that landed Thursday. See the full filing feed and firm-level breakdowns here.
Platform Defendants Put Attorney Solicitation Into California Bellwether Fight
Meta, YouTube and Snapchat asked Los Angeles Superior Court Judge Carolyn B. Kuhl to admit evidence that two plaintiff families responded to lawyer advertising before bringing social-media addiction claims, placing plaintiff credibility into the evidentiary contest ahead of trial. The request in Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047) seeks to make the families’ path to counsel relevant to when they attributed alleged mental-health injuries to the platforms. The court is scheduled to address the question at a Sept. 29 final status conference in a consolidated bellwether involving S.J. and K.D.B. The ruling will determine whether defendants can put attorney solicitation before jurors when the case reaches its *Oct. 28 trial*, potentially reshaping how both sides frame the asserted connection between platform use and harm.
D.C. Circuit Argument Puts PFAS Drinking-Water Standard Under Immediate Pressure
The D.C. Circuit is scheduled to hear challenges to EPA’s 2024 drinking-water standard for six PFAS compounds on Sept. 18, putting the federal baseline for PFOA and PFOS at a judicial inflection point. The American Water Works Association and Association of Metropolitan Water Agencies support national PFOA and PFOS standards but challenge EPA’s additional limits and mixture Hazard Index. EPA now proposes to retain the PFOA and PFOS standards while rescinding requirements for PFHxS, PFNA, GenX and the mixture calculation, concentrating the argument on whether the broader regulation survives. For Aqueous Film-Forming Foams Personal Injury Products Liability Litigation (2873), the argument bears directly on the regulatory benchmark parties will use to test PFAS-exposure and remediation evidence; no decision had issued before the hearing.
Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.
